what happens when you microdose semaglutide How to Semaglutide: Guide Microdosing GLP-1: A Next-Generation Approach

Laboratory research record on GLP-1S [PMID: 39221223] PubMed laboratory record discussing GLP-1S in a research context

Researchers didn't identify the reason for this difference, but the magnitude of the gap drew significant attention

Because our approach emphasizes gradual, steady progress, the changes you experience are more likely to be sustainable and easier to maintain long-term

One recent analysis of six years of medical records from the Department of Veterans Affairs, which reviewed the records of 2 million patients with diabetes, found that those taking a GLP-1 agonist medication had a reduced risk of developing dementia, including Alzheimers, as well as psychiatric and substance use disorders, though it also found an increased risk of gastrointestinal disorders, kidney stones, and pancreatitis

So many adults have thoughtful, medically supported reasons for using a GLP-1